Wipro GE Healthcare Launches AI Enabled Ultrasound System
ECONOMY & POLICY

Wipro GE Healthcare Launches AI Enabled Ultrasound System

Wipro GE Healthcare, a leading global provider of healthcare technologies, announced the launch of the Versana Premier R3, an advanced AI-enabled ultrasound system designed to enhance clinical efficiency and accuracy, streamline workflows, and improve patient outcomes. Catapulting Government’s ‘Make in India’ vision, the state-of-the-art ultrasound system will be manufactured at Wipro GE Healthcare’s PLI factory in Bengaluru.

India’s 1.4Bn population, and a burgeoning NCD problem, underline the need for advanced technologies to enable precise diagnosis, improve clinical accuracy, and reduce the administrative burden. An extension of the Versana ultrasound range, Versana Premier R3 integrates artificial intelligence and offers automation and AI-enabled productivity tools to improve workflow and clinical features designed to enhance clinical efficiency and accuracy. The advanced ultrasound system aims to help clinicians deliver more personalized, ubiquitous, and preventive care. Addressing the skill gap, the system will optimise dynamic tissue imaging, assist with volume calculations, and streamline workflows. Its self-learning onboarding tool will empower the clinicians to enhance their skills and adapt to new workflows.

Chaitanya Sarawate, Managing Director, Wipro GE Healthcare South Asia said, “At Wipro GE Healthcare we continue to make advancements in AI, investing in foundation models that can help enhance precision care, ease clinical workflows and enable better patient outcomes. AI is central to building a future where healthcare is personalized, preventive, and affordable. The launch of our Versana Premier R3, is yet another testament to our commitment towards the delivery of ‘Made in India MedTech – for India and the world.”

Anup Kumar, Business Head, Ultrasound, Wipro GE Healthcare added, “We are very proud to launch the Versana Premier R3, our state-of-the-art our ‘Made in India’ ultrasound system. With the growing NCD burden in the country, there is a pressing need for advanced patient centric technologies that can provide faster, personalized, and more accurate diagnosis. Powered by AI, Versana Premier R3 delivers exceptional image clarity, and versatile organ scanning, enhancing diagnostic precision, and empowering clinicians to make timely and well-informed decisions.”

A rzcent report by PwC indicates that 57% of healthcare providers in India are using AI, significantly higher than the adoption rates globally. As India embraces the potential of artificial intelligence in healthcare, Versana Premier R3 represents a significant leap in diagnostic capabilities. The product’s cutting-edge ‘VisionBoost architecture’ and 8-million-channel digital processing deliver exceptional image clarity. With compatibility for 23 different probes, the system offers dynamic organ scanning.

Wipro GE Healthcare has been pioneering ‘Make in India – for India and the world’ for decades. Other Made in India products from the company’s PLI factory include the Revolution Aspire CT system and Optima IGS320 AI-enabled Cath Lab, among others. Earlier this year, Wipro GE Healthcare also announced an investment of over INR8000 Crores in manufacturing output & local R&D over the next 5 years.

Wipro GE Healthcare, a leading global provider of healthcare technologies, announced the launch of the Versana Premier R3, an advanced AI-enabled ultrasound system designed to enhance clinical efficiency and accuracy, streamline workflows, and improve patient outcomes. Catapulting Government’s ‘Make in India’ vision, the state-of-the-art ultrasound system will be manufactured at Wipro GE Healthcare’s PLI factory in Bengaluru. India’s 1.4Bn population, and a burgeoning NCD problem, underline the need for advanced technologies to enable precise diagnosis, improve clinical accuracy, and reduce the administrative burden. An extension of the Versana ultrasound range, Versana Premier R3 integrates artificial intelligence and offers automation and AI-enabled productivity tools to improve workflow and clinical features designed to enhance clinical efficiency and accuracy. The advanced ultrasound system aims to help clinicians deliver more personalized, ubiquitous, and preventive care. Addressing the skill gap, the system will optimise dynamic tissue imaging, assist with volume calculations, and streamline workflows. Its self-learning onboarding tool will empower the clinicians to enhance their skills and adapt to new workflows. Chaitanya Sarawate, Managing Director, Wipro GE Healthcare South Asia said, “At Wipro GE Healthcare we continue to make advancements in AI, investing in foundation models that can help enhance precision care, ease clinical workflows and enable better patient outcomes. AI is central to building a future where healthcare is personalized, preventive, and affordable. The launch of our Versana Premier R3, is yet another testament to our commitment towards the delivery of ‘Made in India MedTech – for India and the world.” Anup Kumar, Business Head, Ultrasound, Wipro GE Healthcare added, “We are very proud to launch the Versana Premier R3, our state-of-the-art our ‘Made in India’ ultrasound system. With the growing NCD burden in the country, there is a pressing need for advanced patient centric technologies that can provide faster, personalized, and more accurate diagnosis. Powered by AI, Versana Premier R3 delivers exceptional image clarity, and versatile organ scanning, enhancing diagnostic precision, and empowering clinicians to make timely and well-informed decisions.” A rzcent report by PwC indicates that 57% of healthcare providers in India are using AI, significantly higher than the adoption rates globally. As India embraces the potential of artificial intelligence in healthcare, Versana Premier R3 represents a significant leap in diagnostic capabilities. The product’s cutting-edge ‘VisionBoost architecture’ and 8-million-channel digital processing deliver exceptional image clarity. With compatibility for 23 different probes, the system offers dynamic organ scanning. Wipro GE Healthcare has been pioneering ‘Make in India – for India and the world’ for decades. Other Made in India products from the company’s PLI factory include the Revolution Aspire CT system and Optima IGS320 AI-enabled Cath Lab, among others. Earlier this year, Wipro GE Healthcare also announced an investment of over INR8000 Crores in manufacturing output & local R&D over the next 5 years.

Related Stories

Gold Stories

Next Story
Resources

Schindler named among Forbes’ World’s Best Employers 2026

Schindler has been named among Forbes’ World’s Best Employers 2026, a global ranking recognising companies for their workplace environments.Compiled by Forbes in partnership with Statista, the ranking is based on independent employee feedback, including whether employees would recommend their organisation to friends and family.The company said the recognition reflected its focus on creating a workplace where employees can develop their expertise and build careers. ..

Next Story
Infrastructure Urban

India needs an export-execution mindset: Vishesh Jain

Interview with Vishesh Jain, Founder & CEO, EximpleWhat gaps in India’s global trade ecosystem led you to build Eximple, and what problem did you see businesses struggling with most?Eximple came out of a problem that all three founders had seen from different choke points in the trade ecosystem. India has millions of MSMEs and manufacturers, and many of them can make products that are genuinely competitive on quality. Yet only a small fraction is able to build meaningful international businesses. In our experience, the gap is usually not manufacturing capability; it is the ability to exe..

Next Story
Building Material

Nuvoco reports 13.5% revenue growth in Q2 FY27

Nuvoco Vistas Corp. Ltd. reported consolidated revenue of Rs 27.9 billion for Q2 FY27, up 13.5% year on year. Cement sales volume rose 9% to 4.7 million tonnes (MMT), while EBITDA increased 11% to Rs 4.11 billion.The company said it began its cement operations in 2014 with a 2.3 MMT per annum (MMTPA) operation at Nimbol. It now aims to reach 35 MMTPA of cement capacity by FY28, nearly 15 times its initial capacity. Its portfolio spans cement, ready-mix concrete and modern building materials.On sustainability and cost efficiency, Nuvoco partnered with CleanMax for a 46.4 MW wind-solar hybrid re..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code